Key result
A meta-analysis of 46 studies (>10,000 subjects) developed an immunological model for Salk and Sabin vaccines that correlated more highly with immunogenicity data than a per-dose efficacy model.
Why the study?
Do Salk and Sabin polio vaccines improve humoral and mucosal immunogenicity in human subjects?
Meta-Analysis (n=10,000)
Do Salk and Sabin polio vaccines improve humoral and mucosal immunogenicity in human subjects?
A meta-analysis of polio vaccine studies developed an immunological model that accurately measures mucosal immunogenicity of IPV, providing insights for end-game polio immunization policies.
Supports polio end-game policy refinement; extends immunogenicity modeling beyond per-dose efficacy assumptions.
OBJECTIVE: To examine forces that drive vaccination policy to eradicate wild- and vaccine-derived poliovirus, and to focus on the efficacy of vaccines to support decision-making and further research. METHODS: We searched PubMed and Ovid databases for English-language publications, without date restrictions. We also collected references from major reviews on polio vaccine immunogenicity or protection. We conducted a meta-analysis of human immunity to polio infections using multiple non-linear regression, and built a database from a broad (but not systematic) set of polio vaccine studies (46 studies, >10000 subjects). RESULTS: The outcome was an immunological model representative of many different datasets. Parameters measured immunogenicity to both humoral and mucosal immune compartments for Salk and Sabin vaccines. The immunity model was more highly correlated with the data than a simpler per-dose efficacy model. CONCLUSIONS: The model offers new insights for immunization policy. We measured the mucosal immunogenicity of IPV to a precision that is useful in decision-making for end-game polio immunization policies.
No takes yet. Share an insight, caveat, or question.
Behrend et al. (2013) conducted a meta-analysis in Poliovirus infection (n=10,000). Polio vaccines (Salk and Sabin) was evaluated on Immunogenicity to humoral and mucosal immune compartments. A meta-analysis of 46 studies (>10,000 subjects) developed an immunological model for Salk and Sabin vaccines that correlated more highly with immunogenicity data than a per-dose efficacy model.